D. Boral Capital

D. Boral Capital is pleased to announce our Managing Director of Healthcare Research, Jason Kolbert, has initiated coverage on Pulmonx Corporation (Nasdaq: LUNG). This coverage reflects our commitment to providing in-depth analysis of companies in the medical technology industry. Access the full report and Jason’s insights on the D. Boral Capital Research Portal: https://lnkd.in/eZeUQpGT ??www.dboralcapital.com ??[email protected] ??HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #ResearchCoverage #StockAnalysis #LUNG

D. Boral Capital is pleased to highlight our Vice President of Equity Research, Jesse Sobelson initiated coverage on Aduro Clean Technologies Inc. (Nasdaq: ADUR). This coverage reflects our commitment to providing analysis of companies in the Pollution and Treatment Process industry. Access the full report and Jesse’s insights on the D. Boral Capital Research Portal: https://lnkd.in/eei7azxs ??www.dboralcapital.com ??[email protected] ??HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #ResearchCoverage #StockAnalysis #ADUR

D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement. We would like to thank the issuer Plus Therapeutics, Inc., CEO Marc Hedrick, CFO Andrew Sims, issuer counsel William Intner, and D. Boral Capital’s counsel Ross David Carmel, Esq. Additionally, we would like to thank, Investment Banking Associate Stephen Wafalosky, Investment Banking Analyst Varun Ajjarapu, and Capital Markets Analyst Zach Perotto for their collaboration on this transaction. Press Release: https://lnkd.in/efA6-kHb Visit our website to learn more about recent transactions: ??www.dboralcapital.com ?? [email protected] ??HQ: 590 Madison Avenue 39th Floor New York, NY 10022 #DBoralCapital #PSTV #Transaction #InvestmentBank

Today and every day, D. Boral Capital celebrates the heart of our organization: our incredible team members. On this Employee Appreciation Day, we are thankful for our team's dedication and hard work. #DBoralCapital #EmployeeAppreciationDay #GlobalLeadership

D. Boral Capital is pleased to announce our Managing Director of Healthcare Research, Jason Kolbert, has initiated coverage on TEVOGEN BIO Holdings Inc. (Nasdaq: TVGN). This coverage reflects our commitment to providing in-depth analysis of companies in the healthcare industry. To access the D.Boral Capital Research portal, please visit the link below: https://lnkd.in/ewPGwwGB ??www.dboralcapital.com ??[email protected] ??HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #ResearchCoverage #StockAnalysis #TVGN

D. Boral Capital Acted as Joint Bookrunner to LZ Technology Holdings Limited (Nasdaq: LZMH) in connection with its $7.2 Million Initial Public Offering. We would like to thank the issuer, LZ Technology Holdings Limited, issuer counsel Kevin (Qixiang) Sun 孙启翔, underwriting counsels Ying Li and Guillaume de Sampigny, and Stephanie Hu, Partner and Co-Head of Investment Banking at D. Boral Capital, for their collaboration on this transaction. Press Release: https://lnkd.in/eArjeDJ7 Visit our website to learn more about recent transactions: ??www.dboralcapital.com ??[email protected] ??HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #LZMH #TransactionAnnouncement #InvestmentBanking

D. Boral Capital served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering. We would like to thank the issuer Wellgistics Health, Inc., CEO Tim Canning, Chairman of Board Suren Ajjarapu, COO Prasanth Pate, VP of Finance Vishnu Balu, and issuer counsels Kate Bechen and Louis Kern. In addition, we would like to thank the underwriter counsel Ross David Carmel, Esq., Co-Head of Investment Banking Gaurav Verma, Investment Banking Analyst Varun Ajjarapu, and Healthcare Banker Dr. David Sans for their collaboration on this transaction. Press Release: https://lnkd.in/eiuQsQ-u Visit our website to learn more about recent transactions: ??www.dboralcapital.com ?? [email protected] ??HQ: 590 Madison Avenue 39th Floor New York, NY 10022 #DBoralCapital #WGRX #Transaction #InvestmentBank

D. Boral Capital is pleased to highlight our Vice President of Equity Research, Jesse Sobelson initiated coverage on MultiSensor AI Holdings, Inc. (Nasdaq:MSAI) This coverage reflects our commitment to providing in-depth analysis of companies in the tech industry. ??www.dboralcapital.com ??[email protected] ??HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #ResearchCoverage #StockAnalysis #MSAI

Happy Presidents’ Day! Today, we honor the visionary leaders who have shaped our nation's history and values. As we acknowledge the significance of this day, may we be inspired by the leadership and dedication of those who have served our country. ??www.dboralcapital.com ??[email protected] ??HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #PresidentsDay #USA

D. Boral Capital is pleased to highlight our Vice President of Equity Research, Jesse Sobelson initiated coverage on MicroVision? Inc.(Nasdaq: MVIS). This coverage reflects our commitment to providing in-depth analysis of companies in the Hardware industry. ??www.dboralcapital.com ??[email protected] ??HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #ResearchCoverage #StockAnalysis #MVIS